Glycogen synthase kinase 3 (GSK3) is essential for normal development and function of the central nervous system. It is especially important for regulating neurotransmission, although the downstream substrates mediating this function are not yet clear. In the present paper, we report the lipid kinase phosphatidylinositol 4-kinase II α (PI4KIIα) is a novel substrate of GSK3 that regulates trafficking and cell-surface expression of neurotransmitter receptors in neurons. GSK3 phosphorylates two distinct sites in the N-terminus of PI4KIIα (Ser5 and Ser47), promoting binding to the adaptor protein 3 (AP-3) complex for trafficking to the lysosome to be degraded. Blocking phosphorylation reduces trafficking to the lysosome, stabilizing PI4KIIα and its cargo proteins for redistribution throughout the cell. Importantly, a reduction in PI4KIIα expression or phosphorylation increases α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression at the surface of hippocampal neurons. These studies implicate signalling between GSK3 and PI4KIIα as a novel regulator of vesicular trafficking and neurotransmission in the brain.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
November 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
October 23 2014
PI4KIIα phosphorylation by GSK3 directs vesicular trafficking to lysosomes Available to Purchase
James W. Robinson;
James W. Robinson
*Neurosignalling and Mood Disorders Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
Search for other works by this author on:
Iryna Leshchyns’ka;
Iryna Leshchyns’ka
†School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia
Search for other works by this author on:
Hovik Farghaian;
Hovik Farghaian
*Neurosignalling and Mood Disorders Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
Search for other works by this author on:
William E. Hughes;
William E. Hughes
‡Diabetes and Obesity Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
Search for other works by this author on:
Vladimir Sytnyk;
Vladimir Sytnyk
†School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia
Search for other works by this author on:
Graham G. Neely;
Graham G. Neely
1
§Functional Genomics Research Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Adam R. Cole
Adam R. Cole
1
*Neurosignalling and Mood Disorders Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
April 15 2014
Revision Received:
July 17 2014
Accepted:
August 01 2014
Accepted Manuscript online:
August 01 2014
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2014 Biochemical Society
2014
Biochem J (2014) 464 (1): 145–156.
Article history
Received:
April 15 2014
Revision Received:
July 17 2014
Accepted:
August 01 2014
Accepted Manuscript online:
August 01 2014
Citation
James W. Robinson, Iryna Leshchyns’ka, Hovik Farghaian, William E. Hughes, Vladimir Sytnyk, Graham G. Neely, Adam R. Cole; PI4KIIα phosphorylation by GSK3 directs vesicular trafficking to lysosomes. Biochem J 15 November 2014; 464 (1): 145–156. doi: https://doi.org/10.1042/BJ20140497
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |